CAMBRIDGE, MA, Leading genome editing company, today announced that it has raised $120 million in a highly oversubscribed Series B private financing. Read More
MEDFORD, MA, Regenerative medicine company developing cell based therapies for acute organ failure, has announced a Series A investment by Boehringer Ingelheim Venture Fund. Read More